Home > Celexa > Special warnings about Celexa

Special warnings about Celexa

February 19th, 2010 Leave a comment Go to comments

In clinical studies, antidepressants increased the risk of suicidal thinking and behavior in children and adolescents with depression and other psychiatric disorders. Anyone considering the use of Celexa, or any other antidepressant in a child or adolescent, must balance this risk with the clinical need. Celexa has not been studied in children or adolescents and is not approved for treating anyone less than 18 years old.

Additionally, the progression of major depression is associated with a worsening of symptoms and/or the emergence of suicidal thinking or behavior in both adults and children, whether or not they are taking antidepressants. Individuals being treated with Celexa and their caregivers should watch for any change in symptoms or any new symptoms that appear suddenly—especially agitation, anxiety, hostility, panic, restlessness, extreme hyperactivity, and suicidal thinking or behavior—and report them to the doctor immediately. Be especially observant at the beginning of treatment or whenever there is a change in dose.

In recommended doses, Celexa does not seem to impair judgment or motor skills. However, a theoretical possibility of such problems remains, so you should use caution when driving or operating dangerous equipment until you are certain of Celexa’s effect.

There is a slight chance that Celexa will trigger a manic episode. Use Celexa with caution if you suffer from manic-depression (bipolar disorder). Use caution, too, if you are over 60 years old, have liver or kidney problems, suffer from heart disease or high blood pressure, or have ever had seizures.

Click here to order Celexa with FedEx overnight shipping and free prescription, U.S. orders only

All other countries click here to buy Celexa with free shipping

Related posts:

  1. Celexa pregnancy warnings
  2. Celexa breastfeeding warnings

Categories: Celexa Tags:
  1. No comments yet.
  1. No trackbacks yet.
You must be logged in to post a comment.